Log Out

Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by GPS Wealth Strategies Group LLC

Defense World · Sep 30, 2022 06:02

GPS Wealth Strategies Group LLC cut its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 63.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 943 shares of the health services provider's stock after selling 1,627 shares during the period. GPS Wealth Strategies Group LLC's holdings in Teladoc Health were worth $31,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of TDOC. ETF Managers Group LLC boosted its holdings in Teladoc Health by 4.9% in the 4th quarter. ETF Managers Group LLC now owns 3,756 shares of the health services provider's stock worth $354,000 after buying an additional 177 shares during the last quarter. Eaton Vance Management boosted its holdings in Teladoc Health by 97.3% in the 4th quarter. Eaton Vance Management now owns 100,752 shares of the health services provider's stock worth $9,216,000 after buying an additional 49,699 shares during the last quarter. Itau Unibanco Holding S.A. boosted its holdings in Teladoc Health by 24.9% in the 4th quarter. Itau Unibanco Holding S.A. now owns 808 shares of the health services provider's stock worth $76,000 after buying an additional 161 shares during the last quarter. Cubist Systematic Strategies LLC boosted its holdings in Teladoc Health by 501.6% in the 4th quarter. Cubist Systematic Strategies LLC now owns 65,583 shares of the health services provider's stock worth $6,022,000 after buying an additional 54,681 shares during the last quarter. Finally, Credit Agricole S A boosted its holdings in Teladoc Health by 63.3% in the 4th quarter. Credit Agricole S A now owns 24,991 shares of the health services provider's stock worth $2,295,000 after buying an additional 9,684 shares during the last quarter. 92.46% of the stock is currently owned by institutional investors and hedge funds.

Get Teladoc Health alerts:

Analyst Upgrades and Downgrades

Several research firms recently issued reports on TDOC. StockNews.com upgraded Teladoc Health to a "sell" rating in a report on Tuesday, August 9th. SVB Leerink lowered their target price on Teladoc Health from $35.00 to $34.00 and set a "market perform" rating on the stock in a report on Thursday, July 28th. Royal Bank of Canada lowered their target price on Teladoc Health from $53.00 to $35.00 in a report on Wednesday. Needham & Company LLC cut Teladoc Health from a "buy" rating to a "hold" rating in a report on Thursday, July 28th. Finally, Truist Financial initiated coverage on Teladoc Health in a report on Wednesday, September 7th. They set a "hold" rating and a $35.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, twenty-four have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $64.13.

Insider Activity

In related news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares of the company's stock, valued at $990,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Teladoc Health news, insider Arnnon Geshuri sold 4,098 shares of the firm's stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the transaction, the insider now owns 76,182 shares of the company's stock, valued at $2,610,757.14. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the firm's stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now directly owns 26,408 shares in the company, valued at approximately $990,300. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,318 shares of company stock worth $255,321. Corporate insiders own 1.55% of the company's stock.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $26.23 on Friday. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. Teladoc Health, Inc. has a 12-month low of $25.95 and a 12-month high of $156.82. The business's fifty day simple moving average is $33.75 and its 200-day simple moving average is $41.67.

Teladoc Health (NYSE:TDOC – Get Rating) last announced its quarterly earnings data on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.71) by $0.27. The business had revenue of $592.38 million for the quarter, compared to analysts' expectations of $586.86 million. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.54 EPS for the current year.

Teladoc Health Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by GPS Wealth Strategies Group LLC

Analyst Upgrades and Downgrades

Insider Activity

Teladoc Health Price Performance

Teladoc Health Profile

Recommended Stories

Risk Disclaimer